Related Experiment Video
Updated: Aug 17, 2026

Isolation of Murine Peritoneal Macrophages to Carry Out Gene Expression Analysis Upon Toll-like Receptors Stimulation
Published on: April 29, 2015
Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients
Abstract:
Peritoneal macrophages (PMC) from patients undergoing continuous ambulatory peritoneal dialysis (CAPD) were compared to peritoneal macrophages from healthy volunteers and to peripheral blood monocytes (PBM) from CAPD patients, hemodialysis patients, and healthy volunteers. PMC from CAPD patients had morphology similar to PMC and PBM from healthy volunteers. HLA-DR antigen and Fc receptors were present on the cell surface. These monocytes had similar sequential morphologic changes in long-term culture compared to PBM from healthy volunteers. Phagocytosis, hydrogen peroxide generation and bactericidal activity were the same in PMC from CAPD patients as in PBM from healthy volunteers. Chemotaxis and eicosanoid precursor uptake studies suggest that PMC from CAPD patients may be relatively immature bone-marrow-derived cells. Although these cells function well as phagocytes, further study is warranted to define their immune competence, many components of which develop during differentiation into mature macrophages and may therefore be deficient in patients undergoing CAPD.
Insights
Peritoneal macrophages (PMC) from continuous ambulatory peritoneal dialysis (CAPD) patients show good phagocytic function but may be immature. Further research is needed to assess their full immune competence during CAPD.
Area of Science:
- Immunology
- Nephrology
- Cell Biology
Background:
- Continuous ambulatory peritoneal dialysis (CAPD) involves the peritoneum, a site of immune activity.
- Understanding the immune cells within the peritoneal cavity during CAPD is crucial for patient health.
Purpose of the Study:
- To compare peritoneal macrophages (PMC) from CAPD patients with those from healthy individuals and peripheral blood monocytes (PBM).
- To evaluate the functional capacity and differentiation status of PMC in CAPD patients.
Main Methods:
- Morphological analysis of PMC and PBM.
- Assessment of cell surface markers (HLA-DR, Fc receptors).
- Long-term cell culture and functional assays (phagocytosis, hydrogen peroxide generation, bactericidal activity, chemotaxis, eicosanoid precursor uptake).
Main Results:
- PMC from CAPD patients exhibited morphology similar to healthy controls.
- These PMC possessed HLA-DR and Fc receptors and showed comparable phagocytic and bactericidal activities to PBM.
- Chemotaxis and precursor uptake suggested potential immaturity of PMC in CAPD patients.
Conclusions:
- While PMC in CAPD patients function well in phagocytosis, they may represent immature cells.
- Further investigation is required to determine the complete immune competence of these cells, as maturation is essential for full macrophage function.
Related Concept Videos
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

